How long can you take Kadcyla?
- If you have been diagnosed with HER2+ early-stage breast cancer, Kadcyla is given as an intravenous (IV) infusion every 3 weeks for a total of 14 cycles. Treatment with Kadcyla for HER2+ early-stage breast cancer usually lasts less than a year.
- If you have HER2+ metastatic breast cancer that has spread to other parts of the body, Kadcyla is given once every 3 weeks on an ongoing basis.
- In both cases, you may need to stop the medicine if the cancer returns or the side effects become too serious for you to continue treatment.
Kadcyla (ado-trastuzumab emtansine) is a HER2-targeted drug treatment for the treatment of patients with HER2+ breast cancer. Your doctor will determine if you are a candidate for Kadcyla treatment based on a specific test using a tissue sample.
HER2 (human epidermal growth factor receptor 2) is a protein found on the surface of all breast cells. In HER2+ breast cancer, the cells grow and divide too fast because they have too many HER2 receptors.
Learn more: What are HER2 inhibitors?
How is Kadcyla given?
- Kadcyla is given to you as an intravenous (IV) infusion into your vein. You will receive this medicine in your doctor’s office, at a hospital, or at an infusion center.
- Your first infusion will last about 90 minutes. After that, each infusion should take about 30 minutes if you tolerate your first infusion well.
- Your healthcare provider will take extra time to be sure you tolerate the medicine well each time you receive an infusion.
- If you miss a dose of Kadcyla, call your doctor right away to reschedule your appointment. Do not wait until your next regularly scheduled appointment.
Related Questions
- What are monoclonal antibodies?
- What is tdm1 chemotherapy?
- Is Kadcyla a chemotherapy drug? How does it work?
What type of breast cancer does Kadcyla treat?
HER2+ early breast cancer
Kadcyla is used as an adjuvant treatment (after surgery) for patients with early-stage HER2+ breast cancer. It is used when you have received other medicines before your surgery, including a taxane and trastuzumab (Herceptin) and there is cancer remaining in the tissue removed during surgery.
HER2+ metastatic breast cancer
Kadcyla is used in patients with metastatic HER2+ breast cancer that has spread in the body after previous treatment with trastuzumab (Herceptin) and a taxane (either separately or together). Previous treatment could have been for the treatment of cancer that had spread to other parts of the body or for cancer that came back within 6 months of completing adjuvant therapy.
This is not all the information you need to know about Kadcyla (ado-trastuzumab emtansine) for safe and effective use and does not take the place of talking to your doctor about your treatment. Review the full Kadcyla information here, and discuss this information and any questions you have with your doctor or other health care provider.
References
- Kadcyla (ado-trastuzumab emtansine). Prescribing information. Genentech Inc. South San Francisco, CA. 9/2020. Accessed July 22, 2021 at https://www.gene.com/download/pdf/kadcyla_prescribing.pdf
- Kadcyla.com. Genentech Inc. Accessed July 22, 2021 at https://www.kadcyla.com/
Read next
Related medical questions
- Does Kadcyla cross the blood brain barrier?
- Why are my nipples sore? 7 possible causes
- Does anastrozole cause hair loss?
- How do you relieve joint pain associated with tamoxifen or Aromasin?
- What is the success rate of Keytruda?
- Is letrozole a form of chemotherapy?
- What does anastrozole do to your body?
- What is the lifetime or cumulative dose for Adriamycin?
- Does Femara make your hair fall out?
- What is Herceptin? Is Herceptin a chemo drug? How does it work?
- Why give Taxol (Paxel) before carboplatin?
- Does letrozole affect blood sugar levels?
- Will insurance pay for the cost of Ibrance?
- How does AC (Adriamycin and Cytoxan [cyclophosphamide]) work for Breast Cancer?
- What is the success rate for Femara in breast cancer?
- Why do you need to take Xeloda with food?
- Is it common to lose hair AFTER stopping tamoxifen?
- What are the long-term side effects of Adriamycin?
- Which is better - Aromasin or Femara?
- How long can you stay on Herceptin and Perjeta?
- How long do you take Verzenio for?
- How long does Herceptin stay in your body?
- How does Ibrance kill cancer?
- How common is hair loss with Ibrance?
- What is Paxel called in the USA?
- Is Verzenio better than Ibrance?
- Is Ibrance a form of chemo?
- How long can you take Faslodex?
- How effective is Trodelvy?
- What happens after Herceptin treatment?
Drug information
Related support groups
- Kadcyla (5 questions, 10 members)
- Ado-trastuzumab Emtansine (3 questions, 3 members)
- Breast Cancer (119 questions, 304 members)
- Breast Cancer, Metastatic (54 questions, 80 members)